Squarepoint
ELOX

Squarepoint’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Squarepoint’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-342
Closed -$41K – 2964
2020
Q2 		$41K Sell
342
-936
-73% -$106K ﹤0.01% 2117
2020
Q1 		$100K Sell
1,278
-315
-20% -$51.3K ﹤0.01% 1638
2019
Q4 		$469K Buy
1,593
+1,314
+471% +$265K ﹤0.01% 1811
2019
Q3 		$50K Buy
+279
New +$79.4K ﹤0.01% 2242

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Squarepoint's ELOX Position: Q3 2020 in Review

Squarepoint sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2020, closing a stake of 342 shares — an estimated $41K sold.

Squarepoint first reported a position in ELOX in Q3 2019 and held it in 4 quarters. The position peaked at $469K in Q4 2019. 37 funds tracked by Wall St. Rank hold ELOX as of Q3 2020.

  • Squarepoint reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Squarepoint sold 342 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $41K.
  • Squarepoint first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
  • Squarepoint's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $469K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.